References
- Kvale PA, Simoff M, Prakash UB. Lung cancer. Palliative care. Chest 2003; 123: 284S–311S
- Jenis LG, Dunn EJ, An HS. Metastatic disease of the cervical spine. A review. Clin Orthop 1999:89–103.
- Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, Aaronson N, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001; 58: 257–68
- Diener-West M, Dobbins TW, Phillips TL, Nelson DF. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 1989; 16: 669–73
- Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg 1993; 105: 394–7
- Kawanami S, Imada H, Terashima H, et al. Radiotherapy of superior vena cava syndrome. Jpn J Lung Cancer 1996; 36: 77–82
- Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylén U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
- Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 2003; 97: 545–53
- Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999; 56: 67–78
- Clark GM, Sledge GW, Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987; 5: 55–61
- Trachtenberg J. A review of hormonal treatment in advanced prostate cancer. Can J Urol 1997; 4: 61–4
- Glass TR, Tangen CM, Crawford ED, Thompson I. Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning. J Urol 2003; 169: 164–9
- Jones B, Cominos M, Dale RG. Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 736–42
- Lin R, Slater JD, Yonemoto LT, Grove RI, Teichman SL, Watt DK, et al. Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy–dose-volume histogram analysis. Radiology 1999; 213: 489–94
- Goodman KA, Toner S, Hunt M, Wu EJ, Yahalom J. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 2005; 62: 198–206